AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 57 filers reported holding AUTOLUS THERAPEUTICS PLC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 21,346,829 | $40,558,975 | 64.38% |
| TFG Asset Management GP Ltd | 8,300,000 | $15,770,000 | 2.26% |
| Odey Asset Management Group Ltd | 2,499,400 | $4,748,860 | 1.43% |
| Deep Track Capital, LP | 15,000,000 | $28,500,000 | 1.20% |
| Nantahala Capital Management | 7,782,018 | $14,785,834 | 0.96% |
| DAFNA Capital Management LLC | 1,176,150 | $2,234,685 | 0.63% |
| Frazier Life Sciences Management, L.P. | 3,746,857 | $7,119,028 | 0.44% |
| ARMISTICE CAPITAL, LLC | 10,224,000 | $19,425,600 | 0.34% |
| CVI Holdings, LLC | 1,237,511 | $2,351,271 | 0.30% |
| HARBOR CAPITAL ADVISORS, INC. | 145,315 | $276,099 | 0.27% |